Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “γδ T Cells”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableLooking for participantsNCT07237230
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia

Who this might be right for
High-Risk Acute Myeloid Leukemia
Donghua Zhang 40
Not applicableLooking for participantsNCT07144735
What this trial is testing

Allogeneic γδT Cells in Glioblastoma

Who this might be right for
Glioblastoma (GBM)Glioblastoma Multiforme (GBM)
Peking University Third Hospital 18
Not applicableLooking for participantsNCT07782684
What this trial is testing

Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood Transplantation

Who this might be right for
Hematologic Disease and Disorders
Anhui Provincial Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT05358808
What this trial is testing

ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
TC Biopharm 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793435
What this trial is testing

A Phase 1/2 Trial of ADI-212 in mCRPC

Who this might be right for
Prostate Cancer Metastatic
Adicet Therapeutics 12
Not applicableUnknownNCT03379896
What this trial is testing

Study on Antigen-presenting Function of Gamma Delta T Cells in Sepsis and Its Molecular Mechanisms

Who this might be right for
SepsisAntigen-presenting Functionγδ T Cells
West China Hospital 60
Very early researchNot Yet RecruitingNCT06212388
What this trial is testing

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Who this might be right for
Melanoma
Xijing Hospital 10
Not applicableStudy completedNCT05733663
What this trial is testing

TCRγδ+ Cells After Gluten-free Diet: A Biomarker for Coeliac Disease?

Who this might be right for
Celiac Disease
Hospital Mutua de Terrassa 116
Not applicableStudy completedNCT01713829
What this trial is testing

Cranberry Consumption Improves γδ T Cell Function

Who this might be right for
Healthy
University of Florida 52
Early research (Phase 1)Looking for participantsNCT05400603
What this trial is testing

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Who this might be right for
NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more
Emory University 24
Early research (Phase 1)Active Not RecruitingNCT05015426
What this trial is testing

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Who this might be right for
Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)UnknownNCT06404281
What this trial is testing

Γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Changzhou No.2 People's Hospital 9
Very early researchWithdrawnNCT07123662
What this trial is testing

Γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant

Who this might be right for
LeukemiaMyeloidAcute
Guangzhou Bio-gene Technology Co., Ltd
Early research (Phase 1)Enrolling By InvitationNCT06375993
What this trial is testing

Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Who this might be right for
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)+4 more
Adicet Therapeutics 180
Very early researchNot Yet RecruitingNCT06364800
What this trial is testing

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 18
Testing effectiveness (Phase 2)WithdrawnNCT04834128
What this trial is testing

A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19

Who this might be right for
COVID - 19
TC Biopharm
Testing effectiveness (Phase 2)Study completedNCT02425735
What this trial is testing

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Who this might be right for
Liver Cancer
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT06480565
What this trial is testing

A Phase 1/2 Trial of ADI-270 in ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Adicet Therapeutics 60
Early research (Phase 1)Ended earlyNCT04735471
What this trial is testing

ADI-001 in B Cell Malignancies

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 34
Next Page